METHOD FOR SELECTING PATIENTS WITH DIABETES MELLITUS OF TYPE 2 IN RISK GROUP OF DEVELOPING ENDOTHELIAL DYSFUNCTION Russian patent published in 2017 - IPC A61B5/00 A61B8/00 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to endocrinology, and can be used for selecting patients with diabetes mellitus of type 2 in risk group of developing endothelial dysfunction. Performs test with reactive hyperemia test in males. Carry out estimating the time of onset of maximum vasodilatation of brachial artery in comparison with initial. If time of onset of maximum vasodilatation of brachial artery is more than 90.0 s, the patient is taken to a risk group of developing endothelial dysfunction.

EFFECT: method allows to increase the accuracy of prediction of cardiovascular complications, carry out early diagnosis of endothelial dysfunction and increase the quality of therapeutic and diagnostic process owing to assessing the time of onset of maximum vasodilatation of brachial artery during the test with reactive hyperemia.

1 cl, 3 tbl, 3 ex